Skip to main content

Table 2 Prevalence of co-existing conditions at baseline and the course of response during five months of follow-up.

From: Co-morbidity and visual acuity are risk factors for health-related quality of life decline: five-month follow-up EQ-5D data of visually impaired older patients

Co-existing conditions
(n = 296)
Prevalence at baseline
n (% of 296)
Not reported at follow-up
n (%*)
Lost to follow-up
n (%*)
New report at follow-up
n (% of 246)
Diabetes 73 (24.7) 6 (8.2) 10 (13.7) 3 (1.2)
COPD or asthma 32 (10.8) 9 (28.1) 4 (12.5) 5 (2.0)
Heart 67 (22.7) 13 (19.4) 8 (11.9) 8 (3.3)
Stroke 33 (11.2) 6 (18.2) 5 (15.2) 8 (3.3)
Hearing impairments 23 (7.8) 10 (43.5) 5 (21.7) 9 (3.7)
Musculoskeletal 82 (27.8) 18 (22.0) 15 (18.3) 16 (6.5)
Cancer 13 (4.4) 2 (15.4) 4 (30.8) 3 (1.2)
Hypertension 48 (16.3) 14 (29.2) 11 (22.9) 12 (4.9)
Gastrointestinal 15 (5.1) 4 (26.7) 3 (20.0) 6 (2.4)
  1. *Percentages calculated from the number of co-existing disease at baseline, e.g. 6/73 = 8.2%.